# Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

> **NCT01026805** · — · COMPLETED · sponsor: **Hologic, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Abnormal Uterine Bleeding
- Infertility

## Interventions

- **DEVICE:** Interlace Medical 1st Generation Hysteroscopic Morcellator

## Key facts

- **NCT ID:** NCT01026805
- **Lead sponsor:** Hologic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2012-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026805, "Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01026805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*